IDEAYA Biosciences (NASDAQ: IDYA) is a clinical-stage oncology company focused on discovering and developing targeted therapies for cancers with specific genetic alterations. The filing excerpts provided do not contain sufficient detail to describe its revenue model, product pipeline, competitive position, or financial results with the specificity required for a grounded summary. No segment revenue figures, partnership economics, customer concentration data, or competitive landscape details are supported by the excerpts supplied from the 10-K filed 2026-02-17 (accession 000119312526054533). A complete description will require access to the substantive business, financial, and risk sections of that filing.

Source: SEC 10-K, filed 2026-02-17

Industry: Pharmaceutical Preparations Peers: Altimmune Inc Caribou Biosciences Inc HilleVax, Inc. Inhibrx, Inc. Instil Bio Inc Mersana Therapeutics, Inc. Nurix Therapeutics Inc Nkarta Inc